GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EvokAI Creative Labs Inc (TSXV:OKAI) » Definitions » Quality Rank

EvokAI Creative Labs (TSXV:OKAI) Quality Rank


View and export this data going back to 2023. Start your Free Trial

What is EvokAI Creative Labs Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

EvokAI Creative Labs Quality Rank Related Terms

Thank you for viewing the detailed overview of EvokAI Creative Labs's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


EvokAI Creative Labs Business Description

Traded in Other Exchanges
N/A
Address
609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.